Cathie Wood’s ARK Invest Sells Over 300,000 Shares of Iovance Bio

One of the ARK exchange-traded funds run by ETF star Cathie Wood made huge sale on Thursday. This fund sold over 300,000 shares of Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares, as the price of this ETF was down over 1% on Thursday. Note that this fund is still up handily in the past year.

ARK Innovation ETF (NYSEARCA: ARKK) sold 128,163 shares of Iovance. At Thursday’s closing price, this would have valued this sale at $7.0 million. Even though this is a small fraction of the total holdings, every little bit counts. The fund is up 36% in the past year.

Check out all of the ARK Invest sales for Thursday:

FundTickerNameShares
ARKF4477JPBASE22,900
ARKFGOOGALPHABET131
ARKF9923HKYEAHKA252,800
ARKF6060HKZHONGAN ONLINE P&C INSURANCE638,800
ARKGBMYBRISTOL-MYERS SQUIBB29,000
ARKGPSTIPLURISTEM THERAPEUTICS15,505
ARKGRHHBYROCHE32,600
ARKGMCRBSERES THERAPEUTICS400
ARKGSEERSEER20,000
ARKKNSTGNANOSTRING TECHNOLOGIES144,340
ARKKNTDOYNINTENDO38,500
ARKKSESEA71,593
ARKKIOVAIOVANCE BIOTHERAPEUTICS302,190
ARKQBABAALIBABA46,900
ARKQXONEEXONE10,000
ARKWLCLENDINGCLUB32,700
ARKWOKTAOKTA31,041
ARKWSQSQUARE21,732
ARKXTRMBTRIMBLE9,167

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

Source: Read Full Article